Chief Financial Officer of Travere Therapeutics, Inc. (NASDAQ:RTRX), Clague Laura, sells 3,750 shares worth $89,475
According to Travere Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 25 07:00 PM, company Chief Financial Officer, Clague Laura disclosed selling 3,750 shares at a cost of $23.86. At the time of this transaction (Nov 24), this trade was worth $89,475 in total. As of Nov 24, Clague Laura now owns 23,223 shares in total worth about $542,257.05.
For the last few recent trades made by Travere Therapeutics, Inc. (NASDAQ:RTRX) Chief Financial Officer, Clague Laura, we have the following information:
- SEC Form 4 filing: Nov 16: Sold 7,500 shares at the rate of $23.98 per share. Total worth of this trade was $179,813. Total number of shares owned as of Nov 16 were 19,473
- SEC Form 4 filing: Nov 13: Sold 7,500 shares at the rate of $23.61 per share. Total worth of this trade was $177,071. Total number of shares owned as of Nov 13 were 26,973
- SEC Form 4 filing: Sep 23: Sold 1,500 shares at the rate of $18.48 per share. Total worth of this trade was $27,720. Total number of shares owned as of Sep 23 were 19,473
Posted by
George Daniels
on Thursday November 26 2020, 1:58 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
